Published in Vaccine Weekly, April 7th, 2010
In a paper published in the peer-reviewed journal Blood, clinical investigators, led by investigators at Johns Hopkins University, reported on the results of a Phase II study of GVAX AML (immunotherapy) accompanied by immunotherapy-primed lymphocytes after autologous stem cell transplantation in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly